Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.

Synonyms: N-Formimidoylthienamycin, Imipemide, Imipenem, Anhydrous, Anhydrous Imipenem, 71OTZ9ZE0A, 0, Imipenem Anhydrous, MK0787, Q20IM7HE75, MK-0787, N Formimidoylthienamycin, Anhydrous, Imipenem, MK 0787, 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5alpha,6alpha(R*)))-, Imipenem